Trial Profile
A Phase II Study of Milataxel (TL139) Administered Orally in Patients with Malignant Mesothelioma
Status:
Not stated
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 13 Jun 2008
Price :
$35
*
At a glance
- Drugs Milataxel (Primary)
- Indications Malignant-mesothelioma
- Focus Therapeutic Use
- 13 Jun 2008 New trial record.